Table 1 RVA diarrhea between 18 and 104 weeks in vaccinated infants following Rotarix dose 2.
From: Oral rotavirus vaccine shedding as a marker of mucosal immunity
RVA diarrhea N (%) | No RVA diarrhea N (%) | RR (95% CI) | |
|---|---|---|---|
RVA shedding Ct cut-off < 34 | |||
No shedding | 38 (26%) | 106 (74%) | 0.679 (0.415–1.110) |
Shedding | 14 (39%) | 22 (61%) | – |
RVA shedding Ct cut-off < 36 | |||
No shedding | 31 (24%) | 96 (76%) | 0.616 (0.392–0.968) |
Shedding | 21 (40%) | 32 (60%) | – |
RVA-IgA | |||
Seropositive | 7 (18%) | 33 (83%) | 0.533 (0.261–1.090) |
Seronegative | 44 (33%) | 90 (73%) | – |
Shedding plus RVA-IgA | |||
No shedding OR seropositive | 39 (27%) | 108 (73%) | 0.597 (0.362–0.984) |
Shedding AND seronegative | 12 (44%) | 15 (56%) | – |
No shedding AND seropositive | 5 (16%) | 27 (84%) | 0.482 (0.208–1.117) |
Shedding OR seronegative | 46 (32%) | 96 (68%) | – |
